Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-30 Sale |
2021-08-03 5:09 pm |
EYEGATE PHARMACEUTICALS INC | EYEG | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
260,963 | $2.4778 | $646,608 | 785,000 (Indirect) |
View |
| 2021-07-27 Sale |
2021-07-29 7:59 pm |
EYEGATE PHARMACEUTICALS INC | EYEG | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
3,153,138 | $4.6133 | $14,546,264 | 1,045,963 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-02 Tax Withholding |
2021-09-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
61 | $1.81 | 15,260 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:46 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
261 | $2.4 | 69,044 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:46 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
65 | $2.4 | 15,378 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:45 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
63 | $2.4 | 15,321 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:45 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
87 | $2.4 | 23,309 (Direct) |
View |
| 2021-07-26 Option Award |
2021-08-02 5:30 pm |
N/A 2031-07-26 |
EYEGATE PHARMACEUTICALS INC | EYEG | Strem Brian M. President and CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-07-27 Conversion |
2021-07-29 7:59 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
852,500 | $4.8 | 1,045,963 (Indirect) |
View |
| 2021-07-27 Conversion |
2021-07-29 7:59 pm |
2018-04-17 N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
4,092 | $0 | 1,045,963 (Indirect) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:32 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $3.7 | 23,396 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
160 | $3.7 | 15,443 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
154 | $3.7 | 15,384 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
877 | $3.7 | 69,305 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:02 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
878 | $4.19 | 70,182 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:02 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $4.19 | 23,576 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:01 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
155 | $4.19 | 15,603 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:01 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
155 | $4.19 | 15,538 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
889 | $4.13 | 71,060 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
177 | $4.13 | 23,756 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
158 | $4.13 | 15,758 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:56 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
191 | $4.13 | 15,693 (Direct) |
View |
| 2021-04-19 Option Award |
2021-04-21 4:15 pm |
N/A 2031-04-19 |
EYEGATE PHARMACEUTICALS INC | EYEG | Gayron Kenneth L Director |
4,000 | $0 | 4,000 (Direct) |
View |
| 2021-04-19 Option Award |
2021-04-21 4:15 pm |
N/A 2031-04-19 |
EYEGATE PHARMACEUTICALS INC | EYEG | Shapiro Aron Director |
4,000 | $0 | 4,000 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
899 | $4.94 | 71,949 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $4.94 | 23,933 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
194 | $4.94 | 15,916 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
192 | $4.94 | 15,884 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
898 | $5.46 | 72,848 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
218 | $5.46 | 24,113 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
192 | $5.46 | 16,110 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
192 | $5.46 | 16,076 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
10,000 | $0 | 26,302 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
990 | $6.34 | 26,302 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
10,000 | $0 | 26,268 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
988 | $6.34 | 26,268 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
10,000 | $0 | 83,746 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
3,542 | $6.34 | 83,746 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
30,000 | $0 | 54,331 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
1,282 | $6.34 | 54,331 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | TYLE PRAVEEN Director |
3,333 | $0 | 3,333 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:52 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | HANCOCK THOMAS Director |
3,333 | $0 | 3,333 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:52 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | CHANEY PAUL G Director |
3,333 | $0 | 3,333 (Direct) |
View |